Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intermittent levodopa therapy in parkinsonism.

W C Koller

    Advances in Neurology
    |January 1, 1983
    PubMed
    Summary

    Alternate-day levodopa therapy for Parkinson's disease may offer sustained symptom control with fewer side effects. This intermittent approach could preserve brain function and improve long-term treatment effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

    European journal of neurology·2009
    Same author

    A comparison of Parkinson's disease symptoms and self-reported functioning and well being.

    Parkinsonism & related disorders·2008
    Same author

    Topiramate in essential tremor: a double-blind, placebo-controlled trial.

    Neurology·2006
    Same author

    Apolipoprotein E controls the risk and age at onset of Parkinson disease.

    Neurology·2004
    Same author

    Advances in the treatment of Parkinson's disease.

    Drugs of today (Barcelona, Spain : 1998)·2004
    Same author

    Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

    Neurology·2003

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Chronic high-dose levodopa therapy for Parkinson's disease (PD) often leads to reduced efficacy and increased side effects.
    • These limitations impact the long-term effectiveness of levodopa in managing PD symptoms.

    Purpose of the Study:

    • To investigate the efficacy of low-dose alternate-day levodopa therapy in Parkinson's disease.
    • To assess the clinical response and plasma levodopa levels during intermittent levodopa administration.

    Main Methods:

    • Patients with Parkinson's disease received low-dose levodopa on an alternate-day schedule.
    • Clinical responses were monitored on drug administration days and the following day.
    • Plasma levodopa levels were measured to assess drug presence.

    Main Results:

    • Alternate-day levodopa provided adequate control for early parkinsonism but not for late-stage symptoms.
    • Stable clinical responses were observed on both drug and non-drug days, despite negligible plasma levodopa on non-drug days.
    • This regimen resulted in a lower cumulative levodopa dosage.

    Conclusions:

    • Intermittent levodopa therapy may preserve compensatory striatal activity in Parkinson's disease.
    • Further investigation of intermittent levodopa therapy is warranted for potentially effective long-term treatment and an improved therapeutic index.

    Related Experiment Videos